Maryland sets 1st state payment caps on Ozempic, Jardiance

Maryland’s Prescription Drug Affordability Board voted unanimously Nov. 16 to approve final regulations setting upper payment limits on Novo Nordisk’s Ozempic and Boehringer Ingelheim’s Jardiance, the first state payment limits on either drug, according to the Baltimore Sun. The limits are projected to save taxpayers $6.1 million a year. The limits apply to what state […] The post Maryland sets 1st state payment caps on Ozempic, Jardiance appeared first on Becker's Hospital Review | H...

Original Source

Read the full article at Beckershospitalreview →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.